A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation.

Milam, Emily C; Martires, Kathryn J; Lo Sicco, Kristen I; Araten, David J; Franks, Andrew G

Milam, Emily C; Martires, Kathryn J; Lo Sicco, Kristen I; Araten, David J; Franks, Andrew G.

Afiliação

Milam EC; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Martires KJ; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Lo Sicco KI; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Araten DJ; Department of Medicine, Division of Hematology, New York University School of Medicine, New York, New York.
Franks AG; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.

JAAD Case Rep ; 5(3): 228-230, 2019 Mar.

Article em En | MEDLINE | ID: mdl-30809567

Palavras-chave

CyBorD, cyclophosphamide, bortezomib, and dexamethasone; POEMS syndrome; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes; SDH, spontaneous subdural hemorrhage; VEGF, vascular endothelial growth factor; and skin changes; autologous stem cell transplantation; chemotherapy; endocrinopathy; monoclonal gammopathy; polyneuropathy organomegaly

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google